
FUJIFILM Diosynth Biotechnologies confirms £400 million investment plans to create the largest multi-modal biopharmaceutical manufacturing site in the United Kingdom The expansion is expected to create up to 350 highly-skilled jobs on Teesside.
December 2, 2021
Print
The expansion is expected to create up to 350 highly-skilled jobs on Teesside. BILLINGHAM, UK, 2 December 2021 FUJIFILM Diosynth Biotechnologies, a world leading contract development and manufacturing organisation (CDMO) for biologics, viral vaccines and viral vectors, has confirmed a £400 million planned investment package at its UK facility in Billingham, Teesside. This investment package more than doubles the site's existing development and manufacturing footprint, creating the largest multi-modal biopharmaceutical manufacturing site in the United Kingdom1 and is expected to create up to 350 highly-skilled jobs. The new facilities are expected to be operational by late 2023.
The new multi-modal campus will include two new state-of-the-art facilities (a viral gene therapy GMP2 facility and a GMP mammalian cell culture facility) and is part of a 90 Billion Yen global capital investment package initially outlined by FUJIFILM Corporation in June
2021.
We all know that there has never been a more important time to invest in biopharmaceuticals - and £400 million, the largest investment in British biopharmaceutical manufacturing for decades, signals FUJIFILM Diosynth Biotechnologies' intent to be able to offer multi-modal options to respond to our customers' needs with flexibility and agility to help solve public health demands, and deliver the medicines and vaccines of tomorrow, said Martin Meeson, Chief Executive Officer of FUJIFILM Diosynth Biotechnologies. With a strong growing demand for microbial, cell culture and viral gene therapy services, we are adding the capacity and latest technologies within one campus to offer a range of modalities to build an offering that will deliver novel promising treatments to patients for years to come.
I am delighted that Fujifilm has identified the massive potential in the UK for growth and innovation. At £400m, this is a significant investment in British biopharmaceutical manufacturing and will power our response to some of today's most urgent global health challenges and deliver life-changing medicines and vaccines to patients in need said UK Prime Minister, Boris Johnson. It will enable the expansion of the Billingham campus and create 350 new jobs - attracting the best innovators and researchers and bolstering our Life Sciences industry as we build back better from the pandemic.
It's our vision for the FUJIFILM Diosynth Biotechnologies' site in Billingham to be the beating heart of the rapidly expanding North East Life Sciences ecosystem, and this investment will create up to 350 highly-skilled jobs and additional benefits across the local and national supply chain, added Paul Found, Chief Operating Officer, FUJIFILM Diosynth Biotechnologies UK.
The investment will add a new cell culture facility in the expanded Billingham campus and triple existing cell culture capacity capabilities at the site with the addition of 4x2,000L and 2x500L single use bioreactor production capabilities for the manufacture of both monoclonal and novel antibody treatments. This expansion will also include the addition of the company's MaruX GMP continuous manufacturing platform to provide customers with a differentiated connected and integrated production platform offering.
In addition to the cell culture facility, the new investment package will expand the viral vector and gene therapy services offered by FUJIFILM Diosynth Biotechnologies from the UK with dedicated process development capabilities and a commercial-scale viral gene therapy GMP facility, both located on the Billingham campus. This expansion will deliver a ten-fold increase in gene therapy production capabilities by FUJIFILM Diosynth Biotechnologies in the UK, cementing its leadership in the viral vector market; and complementing its existing global footprint including sites in College Station, Texas and Watertown, Massachusetts, both in the USA. The investment will also facilitate the expansion of existing capabilities in vaccine manufacturing, along with new capabilities including mRNA production.
FUJIFILM Diosynth Biotechnologies previously announced plans to expands its viral vector and gene therapy offerings in Darlington, UK, with process development laboratories and manufacturing capabilities to support the production of investigational use of gene therapies in early-stage clinical trials (first-in-human). The process development laboratories have already begun operations, with GMP manufacturing services starting in spring 2022.
Further to this, an expansion of the existing 5,000L GMP microbial production facilities will also take place at the Billingham campus. This expansion will increase microbial fermentation capacity by almost two-thirds. The expansion will include over 20,000 sq. ft of modular downstream clean room space, including two primary recovery and refolding suites, two purification suites and a column packing room. It is designed to implement FUJIFILM Diosynth Biotechnologies' SymphonX 3 technology. The expansion also includes quality control (QC) labs, office space and materials storage. This expansion will be operational by late 2023/early 2024.
1 Based on internal company research as of December 2021.
2 Good manufacturing practice
Media contact:
Andy Ross
Deputy Head of Corporate Communications - Europe
FUJIFILM Europe GmbH
Tel: +44(0)7766497949
Images FUJIFILM Diosynth Biotechnologies, Billingham, Teesside
FDB 1 [JPG]
FDB 2 [JPG]
FUJIFILM Diosynth Biotechnologies, Billingham, Teesside [JPG]
Most recent headlines
05/01/2027
Worlds first 802.15.4ab-UWB chip verified by Calterah and Rohde & Schwarz to be ...
07/10/2026
Dalet, a leading technology and service provider for media-rich organizations, today announced the latest Long-Term Supported (LTS) release of Dalet Flex. Build...
06/09/2026
June 9 2026, 23:00 (PDT) Dolby and MagentaTV Bring Fans Closer to the FIFA Worl...
02/09/2026
Professional and collegiate clubs, leading vendors discuss current trends in stadium production
On. Aug. 12, the 2026 SVG Venues & Teams Summit explored the ev...
02/09/2026
SoFi Stadium, YouTube Theater, and Hollywood Park have completed an infrastructure upgrade expanding game presentation and broadcast production capabilities acr...
02/09/2026
Comcast Technology Solutions (CTS) has announced a suite of AI-powered workflow applications for broadcasters, content owners, and operators, built on its Video...
02/09/2026
The North American Broadcasters Association (NABA) and the Association of Professional Wireless Production Technologies (APWPT) have announced a partnership to ...
02/09/2026
Carolina Hurricanes, Anaheim Ducks, Columbus Blue Jackets, Dallas Stars, Minneso...
02/09/2026
New LED provides enhanced quality control, quicker show prep, detailed productio...
02/09/2026
Combines the Phat Drive with high-voltage valve circuit
The latest pedal from Keeley Electronics combines their popular Phat Mode drive pedal with an all-ne...
02/09/2026
Free version of virtual mixing room plug-in introduced
Lewitt's Space Replicator plug-in provides users with a virtual monitoring environment that aims ...
02/09/2026
Two new mixing & mastering plug-ins revealed
AIR Music Tech have just introduced the Stereophonic Bundle, a pair of processing plug-ins designed to provide ...
02/09/2026
Rohde & Schwarz has achieved initial verification of 3GPP Rel. 17 power-saving f...
02/09/2026
Bilbao - 3rd September 2026 -AgileTV, a leading provider of end-to-end TV and vi...
02/09/2026
Why agentic media supply chains need experience design built around visibility, reversibility and human authority
When AI can generate a functional interface ...
02/09/2026
Six-country survey finds 26% of sports fans frequently unable to determine where...
02/09/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
02/09/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
02/09/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
02/09/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
02/09/2026
KOKKEDAL, DENMARK, SEPTEMBER 1, 2026 DPA Microphones announces its new 6388 CORE Headset Microphone, a high-performance directional headset designed for dema...
02/09/2026
Pliant Technologies will highlight its CrewCom CXD 32CF 32x32 Dante /AES67 Digital Audio Network Interface, a powerful connectivity solution designed to expand ...
02/09/2026
iWedia, a leading provider of software solutions for connected TV devices, today announced two enhancements to Teatro Pulse, its end-to-end TV service operation...
02/09/2026
Signiant, trusted by the media industry for accelerated content movement for more than 20 years, will showcase the latest evolution of the Signiant Platform at ...
02/09/2026
With a contractual agreement to supply a leading UK sports broadcaster with outside broadcast services for 104 football matches per season over the next four ye...
02/09/2026
IBC2026 will put sport firmly at the centre of the global media and entertainment technology conversation with the strongest sports showing in the event's h...
02/09/2026
PTZOptics will bring a hands-on showcase of intelligent video production to IBC2026 (11-14 September, RAI Amsterdam), with demonstrations spanning new camera te...
02/09/2026
OOONA, a global provider of professional management and production tools for the media localization industry, today announced the launch of OOONA Go, a ready-to...
02/09/2026
EON Media will make its European debut at IBC2026 (September 11-14, RAI Amsterdam) in the show's Future Tech Zone (Hall 14.FT5). The company is launching it...
02/09/2026
Frequency, the engine behind many of the worlds leading streaming television channels, will demonstrate at IBC2026 how integrating intelligence throughout chann...
02/09/2026
On-device AI platform gives broadcasters and content creators purpose-built tools for real-time vertical video production and AI-enhanced sports coverage...
02/09/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
02/09/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
02/09/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
02/09/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
02/09/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
02/09/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
02/09/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
02/09/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
02/09/2026
Next-Generation Freeform Control Surfaces Lay the Foundation for AI-Enabled Media Operations
At IBC2026 (Sept. 11 14, RAI Amsterdam, Stand #1.B73), Imagine Com...
02/09/2026
Friedrichstadt-Palast in Berlin, the world's largest theater stage, has modernized its backstage production infrastructure with a comprehensive Riedel solut...
02/09/2026
Women in Media announces that it will host the two-day Reel/Forward in-person conference devoted to navigating today's production scene. Guests can enjoy pa...
02/09/2026
The expanded partnership brings Teradek's Live Production solutions to New Media AV's European dealer and integrator network, opening new opportunities ...
02/09/2026
QuickLink, a leading provider of award-winning video production and remote guest contribution solutions, announces a major expansion to its award winning Studio...
02/09/2026
BCNEXXT, the developers of the advanced playout platform Vipe, today announced that premium entertainment brand Foxtel has selected Vipe to underpin playout for...
02/09/2026
SubtitleNEXT helps HOT Telecom's subtitling team keep a cool head with reliable QC capabilities
Profuz Digital, global developer of digital media and local...
02/09/2026
Case Study: Mission Digital Strengthens Battery Safety with Safe-ion
As productions become increasingly dependent on battery-powered equipment, the safe storag...
02/09/2026
LA JOLLA, CA-Influenza viruses constantly shapeshift to evade recognition by the immune system. This shapeshifting occurs in critical proteins like hemagglutini...
02/09/2026
LA JOLLA, CA-Clinicians often use a medical test called a 12-lead electrocardiogram (ECG) to diagnose heart problems, which uses electrodes placed on the chest ...
02/09/2026
LA JOLLA, CA-Proteins may look like rigid molecular structures, but inside our c...